SynthesisPLoS medicine2013
Interactions between non-physician clinicians and industry: a systematic review.
Synthesis in PLoS medicine, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Pooled it
- Food industry's interactions with nutrition professionals in Australia: a survey.Public health nutrition · 2026Article
- Healthcare professionals' perspectives on commercial milk formula marketing in the UK: a qualitative study.Archives of disease in childhood · 2025Article
- Assessing Artificial Intelligence Solution Effectiveness: The Role of Pragmatic Trials.Mayo Clinic proceedings. Digital health · 2024Review
- 'Public health nutrition · 2024Article
- A descriptive survey of specialty pharmacy team members' perceptions of interactions with field representatives from pharmaceutical companies.Journal of managed care & specialty pharmacy · 2023Article
- Interactions Between Nutrition Professionals and Industry: A Scoping Review.International journal of health policy and management · 2023Article
- Evaluation of Industry Payments to US Advanced Practice Clinicians in 2021.JAMA network open · 2022Article
- Exploring healthcare professionals' views of the acceptability of delivering interventions to promote healthy infant feeding practices within primary care: a qualitative interview study.Public health nutrition · 2021Article
- Article
- A comparison of educational events for physicians and nurses in Australia sponsored by opioid manufacturers.PloS one · 2021Article
- The intersections of industry with the health research enterprise.Health research policy and systems · 2019Article
- A cross-sectional study of all clinicians' conflict of interest disclosures to NHS hospital employers in England 2015-2016.BMJ open · 2018Article
- Article
- Influence of pharmaceutical marketing on Medicare prescriptions in the District of Columbia.PloS one · 2017Article
- Food for thought? Potential conflicts of interest in academic experts advising government and charities on dietary policies.BMC public health · 2016Article
- Physicians-Pharmaceutical Sales Representatives Interactions and Conflict of Interest: Challenges and Solutions.Inquiry : a journal of medical care organization, provision and financing · 2016Article
- Same song, different audience: pharmaceutical promotion targeting non-physician health care providers.PLoS medicine · 2013Article
- Pharmaceutical Clinical Educators: A Resource for Advanced Practice Providers.Journal of the advanced practitioner in oncologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundWith increasing restrictions placed on physician-industry interactions, industry marketing may target other health professionals. Recent health policy developments confer even greater importance on the decision making of non-physician clinicians. The purpose of this systematic review is to examine the types and implications of non-physician clinician-industry interactions in clinical practice. METHODS AND
findingsWe searched MEDLINE and Web of Science from January 1, 1946, through June 24, 2013, according to PRISMA guidelines. Non-physician clinicians eligible for inclusion were: Registered Nurses, nurse prescribers, Physician Assistants, pharmacists, dieticians, and physical or occupational therapists; trainee samples were excluded. Fifteen studies met inclusion criteria. Data were synthesized qualitatively into eight outcome domains: nature and frequency of industry interactions; attitudes toward industry; perceived ethical acceptability of interactions; perceived marketing influence; perceived reliability of industry information; preparation for industry interactions; reactions to industry relations policy; and management of industry interactions. Non-physician clinicians reported interacting with the pharmaceutical and infant formula industries. Clinicians across disciplines met with pharmaceutical representatives regularly and relied on them for practice information. Clinicians frequently received industry "information," attended sponsored "education," and acted as distributors for similar materials targeted at patients. Clinicians generally regarded this as an ethical use of industry resources, and felt they could detect "promotion" while benefiting from industry "information." Free samples were among the most approved and common ways that clinicians interacted with industry. Included studies were observational and of varying methodological rigor; thus, these findings may not be generalizable. This review is, however, the first to our knowledge to provide a descriptive analysis of this literature.
conclusionsNon-physician clinicians' generally positive attitudes toward industry interactions, despite their recognition of issues related to bias, suggest that industry interactions are normalized in clinical practice across non-physician disciplines. Industry relations policy should address all disciplines and be implemented consistently in order to mitigate conflicts of interest and address such interactions' potential to affect patient care. Please see later in the article for the Editors' Summary.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.